期刊文献+

Cyclin D1在腮腺多形性腺瘤及瘤旁涎腺组织中的表达 被引量:2

Expression of Cyclin D1 in Salivary Pleomorphic Adenoma and Adjacent Tumor Gland Tissues
暂未订购
导出
摘要 目的:检测Cyclin D1在腮腺多形性腺瘤及瘤旁涎腺组织中mRNA和蛋白水平的表达,探讨其在腮腺多形性腺瘤发生发展中的作用。方法:分别通过RT-PCR和Western blot方法检测Cyclin D1在原发腮腺多形性腺瘤与瘤旁涎腺组织中mRNA和蛋白水平的表达情况;另外采用免疫组化法检测Cyclin D1在原发腮腺多形性腺瘤以及瘤旁涎腺组织石蜡组织标本中蛋白水平的表达情况。结果:RT-PCR和Western blot检测结果显示,CyclinD1在组织标本中mRNA和蛋白水平不仅在于肿瘤组织中有较强的表达,而且瘤旁涎腺组织中Cyclin D1也有一定量的表达。免疫组化检测结果显示,Cyclin D1在腮腺多形性腺瘤组织中有较高的表达,而在瘤旁涎腺组织中未见明显表达。结论:Cyclin D1可能参与腮腺多形性腺瘤的发生发展,有助于为临床诊断治疗提供一定的参考依据。 Objective:To detect the mRNA and protein expression levels of Cyclin D1 in the parotid pleomorphic adenoma and adjacent tumor tissues,to explore the role of Cyclin D1 gene in pleomorphic adenoma.Methods:RT-PCR and Western Blot were used to detect the mRNA and protein expression levels of Cyclin D1 in primary parotid pleomorphic adenoma and adjacent tumor tissues.Immunohistochemistry was also applied to detect the expression of Cyclin D1 in paraffin embedded primary parotid pleomorphic adenoma tissues and adjacent tumor tissues.Results:As shown by RT-PCR and Western blot,Cyclin D1 expressed both in tumor tissues and adjacent tumor tissues of pleomorphic adenoma.Compared to its higher expression in tumor samples,the expression of Cyclin D1 in adjacent tumor tissues was relatively weaker.However,immunohistochemical results showed that Cyclin D1 was restrictively detected in tumor tissues of parotid pleomorphic adenoma,but none in adjacent tumor tissues.Conclusion:Cyclin D1 may play a role in the occurrence of pleomorphic adenoma.The detection of Cyclin D1 might provide information for prognosis and treatment of parotid pleomorphic adenoma.
出处 《口腔医学研究》 CAS CSCD 2012年第12期1254-1256,1261,共4页 Journal of Oral Science Research
基金 上海市科学技术委员会资助项目(编号:08JC1414400) 上海市重点学科建设项目(编号:S30206)
关键词 腮腺多形性腺瘤 CYCLIN D1 增殖 Parotid pleomorphic adenoma Cyclin D1 Proliferation
  • 相关文献

参考文献8

  • 1Takahashi-Yanaga F, Sasaguri T. GSK-3β regulates cy- clinD1 expression.. Anewtargetforehemotherapy [J]. Cellular- Signal,2008,20(4) : 581-589.
  • 2Michalides R, van Veelen N, Kristel PM, et al. Overexpres- sion of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck [J]. Arch Otolaryngol Head Neck Surg, 1997, 123 :497-502.
  • 3Zwijsen RM, Wientjens E, Klompmaker R, et al. CDK-in-dependent activation of estrogen receptor by cyclin D1 [J]. Ce11,1997,88 : 405-415.
  • 4Donnellan R, Chetty R. Cyclin D1 and human neoplasia [J]. J Clin Pathol: Mol Part,1998,51: 1-7.
  • 5Fracchiolla NS, Pruneri G, Pignataro L, et al. Molecular and immunohistochemieal analysis of the bel-1/ cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein ex- pression with lymph node metastasis and advanced clinical stage[J]. Cancer,1997,79 : 1114-1121.
  • 6Zeng T, Yamamoto H, Bowen E, et al. Cell Cycle control in isoproternol-induced murine salinary acinar cell proliferation [J]. CompBiochemPhysiol, 1996, 115(3) : 271-279.
  • 7谢青,徐飞,汤金梁,王亚丽.涎腺多形性腺瘤的交界性生物学行为的探讨[J].第三军医大学学报,2002,24(8):961-963. 被引量:7
  • 8许宁,朱恩新,张茜,刘婷姣.Cyclin D1和Ki67与涎腺腺样囊性癌发生及预后的相关性研究[J].口腔医学研究,2010,26(1):22-25. 被引量:12

二级参考文献18

  • 1陈玲,万飞.涎腺腺样囊性癌p16-pRB-cyclinD1通路的研究[J].实用老年医学,2006,20(3):166-168. 被引量:4
  • 2Lauren V 回允中(译).阿克曼外科病理学[M].沈阳:辽宁教育出版社,1999.815.
  • 3Chen CH, Shen J, Lee WJ, et al. Overexpression of cyclin D1 and c--Myc gene products in human primary epithelial ovarian cancer [J]. Int J Gynecol Cancer, 2005, 15(5) : 878 - 883.
  • 4Buchynska LG, Nesina IP, Yurchenko NP, et al. Expression of p53, p21WAF1/CIP1, p161NK4A and Ki--67 proteins in serous ovarian tumors [J]. Exp Oncol, 2007, 29(1) : 49- 53.
  • 5Bartkova J, Lukas J, Stranss M, et al. Cell cycle- related variation and tissue- restrieted expression of human cyclin D1 protein [J]. J Pathol, 1994, 172 : 237-245.
  • 6Toyoshima F, Moriguchi T, Wada H, et al. Nuclear export of Cyclin D1 and its possible role in DNA damage-- induced check point [J]. J EMBO, 1998, 17 : 2728- 27215.
  • 7Zhou CX, Gao Y. Aberrant expression of beta- catenin, Pin1 and Cyclin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis [J]. Oncol Rep, 2006, 16 : 505- 511.
  • 8Etges A, Nunes FD, Ribeiro KCB, et al. Immuohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumors[J]. Oral Oncol, 2004, 40: 326- 331.
  • 9Samuel S, Brain PR, Marcia LL, et al. Prognostic Value of KIT mutation type, mitotic activity, and bistologic subtype in gastrointestinal stromal [J]. J Glin Oncol, 2002, 20 : 3898-3905.
  • 10Murakami M, Ohtani I, Hojo H, et al. Immunohistochemical evaluation with Ki67 and application to salivary gland tumors [J]. Laryngol Otol, 1992, 106(1) :35-38.

共引文献17

同被引文献27

  • 1Drummond S, Canavarro C, Perinetti G, et al. The monitoring of gingival crevicular fluid volume during orthodontic treatment: a longitudinal randomized split-mouth study [ J ]. Eur J Orthod, 2012,34 ( 1 ) :109-113.
  • 2Krishnan V, Davidovitch Z. Cellular, molecular, and tissue-level reactions to orthodontic force [ J ]. Am J Orthod Dentofacial Or- thop, 2006,129(4) :469.
  • 3Thoms HC, Dunlop MG, Stark LA. p38-mediated inactivation of eyelin D1/eyclin-dependent kinase 4 stimulates nucleolar transloca- tion of RelA and apoptosis in eoloreetal cancer cells [ J ]. Cancer Res, 2007,67 (4) : 1660-1669.
  • 4Fukuchi M, Fukai Y, Kimura H, et al. Prolyl isomerase Pinl ex- pression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression [ J ]. Int J Oncol, 2006,29(2) :329-334.
  • 5Shiozaki H, Doki Y, Yamana H, et al. A multi-institutional study of immunohistochemical investigation for the roles of cyclin D1 and E-cadhefin in superficial squamous cell carcinoma of the esophagus [J]. J Surg Oncol, 2002,79(3) :166-173.
  • 6JHA A K, NIKBAKHT M, JAIN V,et al. pl6(INK4a) and pl5(INK4b) gene promoter methylation in cervical cancer patients[J]. Oncol Lett, 2012, 3(6) : 1331 - 1335.
  • 7KO E, KIM Y, KIM S J, et al. Promoter hypermethylation of thepi 6 gene is associated with poor prognosis in recurrent early - stagehepatocellular carcinoma[ J]. Cancer Epidemiol Biomarkers Prev,2008,17(9) : 2260 -2267.
  • 8U G, JI Y,LIU C,et al. Reduced levels of pl5INK4b,pl6INK4a, p21cipl and p27kipl in pancreatic carcinoma [ J ].Mol Med Rep, 2012, 5(4) : 1106-1110.
  • 9BAI P, XIAO X,ZOU J,et al. Expression of pl4(ARF),pl5(INK4b) , pl6 ( INK4a) and skp2 increases during esophagealsquamous cellcancer progression [ J ]. Exp Ther Med, 2012,3(6): 1026 -1032.
  • 10AL ANSARI M M, HENDRAYANI S F,TULBAH A,et al.pl6INK4A represses breast stromal fibroblasts migration/invasionand their VEGF - A - dependent promotion of angiogenesis throughAkt inhibition[J]. Neoplasia, 2012,14(12) : 1269 -1277.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部